Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12001
Idaho Strategic Resources
IDR
$505M
| $52.5K | ﹤0.01% |
+10,780
| New | +$57.7K |
|
12002
PUT
Root
ROOT
$797M
| $52.3K | ﹤0.01% |
11,600
+3,800
| +49% | +$19.3K |
|
12003
CALL
Spruce Power Holding Corp
SPRU
$35.4M
| $52.2K | ﹤0.01% |
7,963
-17,062
| -68% | -$146K |
|
|
WKME
12004
CALL
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $52.1K | ﹤0.01% |
+4,900
| New | +$49.9K |
|
|
ALLK
12005
PUT
DELISTED
Allakos
ALLK
| $52.1K | ﹤0.01% |
11,700
+11,100
| +1,850% | +$71K |
|
12006
PUT
Gossamer Bio
GOSS
$75.4M
| $52K | ﹤0.01% |
41,300
-63,100
| -60% | -$121K |
|
12007
PUT
Coherus Oncology
CHRS
$185M
| $52K | ﹤0.01% |
7,600
-31,400
| -81% | -$244K |
|
|
VERV
12008
PUT
DELISTED
Verve Therapeutics
VERV
| $51.9K | ﹤0.01% |
3,600
-5,200
| -59% | -$102K |
|
12009
PUT
Xeris Biopharma Holdings
XERS
$1.57B
| $51.8K | ﹤0.01% |
31,800
-32,600
| -51% | -$40.8K |
|
12010
PUT
Rekor Systems
REKR
$98.2M
| $51.8K | ﹤0.01% |
41,400
+29,300
| +242% | +$46.6K |
|
12011
Biomerica
BMRA
$4.88M
| $51.6K | ﹤0.01% |
3,451
-2,339
| -40% | -$50.4K |
|
12012
CALL
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.26B
| $51.6K | ﹤0.01% |
700
-100
| -13% | -$7.54K |
|
12013
CALL
American Coastal Insurance
ACIC
$466M
| $51.6K | ﹤0.01% |
18,300
+9,400
| +106% | +$18.9K |
|
12014
PUT
Telephone and Data Systems
TDS
$4.05B
| $51.5K | ﹤0.01% |
4,900
-20,900
| -81% | -$244K |
|
12015
Lightpath Technologies
LPTH
$953M
| $51.5K | ﹤0.01% |
36,492
+13,453
| +58% | +$20.9K |
|
12016
PUT
Alector
ALEC
$219M
| $51.4K | ﹤0.01% |
8,300
+200
| +2% | +$1.63K |
|
12017
CALL
Kura Oncology
KURA
$966M
| $51.4K | ﹤0.01% |
4,200
-2,400
| -36% | -$29.9K |
|
|
PFSW
12018
PUT
DELISTED
PFSweb, Inc.
PFSW
| $51.3K | ﹤0.01% |
12,100
-16,900
| -58% | -$105K |
|
|
MRCC
12019
CALL
DELISTED
Monroe Capital Corp
MRCC
| $51.3K | ﹤0.01% |
6,700
+2,600
| +63% | +$21.1K |
|
12020
CALL
Cytosorbents Corp
CTSO
$25.1M
| $51.2K | ﹤0.01% |
+15,200
| New | +$45.6K |
|
12021
PUT
Columbia Financial
CLBK
$1.23B
| $51.2K | ﹤0.01% |
2,800
-2,200
| -44% | -$44.6K |
|
12022
CALL
Invesco S&P 500 GARP ETF
SPGP
$2.33B
| $51.2K | ﹤0.01% |
+600
| New | +$51.9K |
|
|
FM
12023
PUT
DELISTED
iShares Frontier and Select EM ETF
FM
| $51.2K | ﹤0.01% |
+2,000
| New | +$51.3K |
|
12024
PUT
Protalix BioTherapeutics
PLX
$179M
| $51K | ﹤0.01% |
24,300
+7,000
| +40% | +$12.3K |
|
12025
PUT
Odyssey Marine Exploration
OMEX
$52.9M
| $51K | ﹤0.01% |
15,700
+14,700
| +1,470% | +$47.2K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.